biote (BTMD) Expected to Announce Quarterly Earnings on Wednesday

biote (NASDAQ:BTMD - Get Free Report) is projected to issue its quarterly earnings data after the market closes on Wednesday, March 12th. Analysts expect the company to announce earnings of $0.09 per share and revenue of $51.20 million for the quarter. Persons that wish to listen to the company's earnings conference call can do so using this link.

biote Trading Up 1.2 %

Shares of BTMD traded up $0.05 during mid-day trading on Friday, reaching $4.26. The company had a trading volume of 103,228 shares, compared to its average volume of 134,371. biote has a fifty-two week low of $4.03 and a fifty-two week high of $8.44. The firm has a fifty day simple moving average of $5.22 and a 200-day simple moving average of $5.64. The stock has a market cap of $231.48 million, a price-to-earnings ratio of 16.38 and a beta of 1.07.

Wall Street Analyst Weigh In

Separately, Craig Hallum began coverage on biote in a research note on Monday, December 16th. They set a "buy" rating and a $12.00 price target for the company.

biote Company Profile

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support.